|
||||||||||||||||||
|
||||||||||||||||||
|
|||||||||||
DescriptionThe 2G8 monoclonal antibody reacts with mouse CD23, a 45 kDa type II transmembrane glycoprotein. CD23 is expressed on resting conventional B cells, and its expression is modulated upon B-cell activation. The B-1 cell lineage (CD5+ B cells) does not express CD23. Soluble forms of the antigen have been reported to be biologically active. CD23 is a low affinity receptor for IgE and is thought to play a role in the regulation of IgE response and B-cell activation. CD21 is thought to bind to CD23. Applications ReportedFor research use only, not for diagnostic or therapeutic use. The 2G8 antibody has been reported for use in flow cytometric analysis. Applications TestedThe 2G8 antibody has been tested by flow cytometric analysis of mouse splenocyte suspensions. This can be used at less than or equal to 0.125 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Rabin, E., Y. Z. Cong, et al. 1992. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages. Ann N Y Acad Sci 651: 130-42. Cong, Y. Z., E. Rabin, et al. 1991. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol 3(5): 467-76. Related ProductsCat. 11-0232 FITC anti-mouse CD23 (FceRII) (clone B3B4) Cat. 12-0232 PE anti-mouse CD23 (FceRII) (clone B3B4) Cat. 13-0232 Biotin anti-mouse CD23 (FceRII) (clone B3B4) Cat. 14-0232 Affinity Purified anti-mouse CD23 (FceRII) (clone B3B4) Cat. 12-4321 PE Rat IgG2a Isotype Control |
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |